Boji Medical Technology Co.,Ltd. (SHE:300404)
China · Delayed Price · Currency is CNY 10.70
+0.08 (0.75%)
At close: Feb 12, 2026
Boji Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 7.41 | 28.78 | 24.34 | 27.67 | 38.88 | 16.99 |
Depreciation & Amortization | 26.77 | 26.77 | 23.25 | 21.5 | 17.88 | 15 |
Other Amortization | 4.11 | 4.11 | 4.23 | 2.83 | 1.46 | 1.51 |
Loss (Gain) From Sale of Assets | 0.21 | 0.21 | 0 | - | - | - |
Asset Writedown & Restructuring Costs | 0.08 | 0.08 | 0.03 | 0.07 | 0.3 | - |
Loss (Gain) From Sale of Investments | -3.04 | -3.04 | -2.78 | -3.75 | -2.36 | -2.98 |
Provision & Write-off of Bad Debts | 20.38 | 20.38 | 15.36 | 14.92 | 8.32 | 10.68 |
Other Operating Activities | 53.78 | 8.58 | 7.62 | 7.27 | 7.79 | 10.8 |
Change in Accounts Receivable | -108.31 | -108.31 | -45.55 | -52.26 | -22.47 | -2.25 |
Change in Inventory | 8.24 | 8.24 | -33.51 | -23.49 | -56.55 | -1.28 |
Change in Accounts Payable | 60.08 | 60.08 | 57.01 | 41.35 | 38.69 | 50.74 |
Operating Cash Flow | 50.62 | 26.78 | 35.95 | 28.14 | 30.1 | 97.07 |
Operating Cash Flow Growth | 125.70% | -25.52% | 27.77% | -6.52% | -68.99% | 112938.88% |
Capital Expenditures | -18.96 | -29.35 | -62.2 | -117.73 | -53.99 | -31.42 |
Sale of Property, Plant & Equipment | 0.45 | 0.46 | 0.01 | 0.01 | 0.11 | - |
Investment in Securities | -14.18 | -40.98 | 26.42 | -47.71 | -42.13 | 1.72 |
Other Investing Activities | 1.09 | 3.02 | 2.68 | 3.41 | 2.49 | 0.51 |
Investing Cash Flow | -31.6 | -66.85 | -33.1 | -162.02 | -93.52 | -29.19 |
Short-Term Debt Issued | - | - | - | - | - | 51.98 |
Long-Term Debt Issued | - | 8.33 | 56.02 | 75.31 | 25.13 | - |
Total Debt Issued | 43.94 | 8.33 | 56.02 | 75.31 | 25.13 | 51.98 |
Short-Term Debt Repaid | - | - | - | - | - | -35 |
Long-Term Debt Repaid | - | -75.61 | -27.71 | -28.67 | -33.79 | -0.32 |
Total Debt Repaid | -71.87 | -75.61 | -27.71 | -28.67 | -33.79 | -35.32 |
Net Debt Issued (Repaid) | -27.93 | -67.29 | 28.31 | 46.64 | -8.66 | 16.66 |
Issuance of Common Stock | 27.7 | 3.35 | 94.59 | 12.14 | 348.2 | 8.74 |
Repurchase of Common Stock | -15.65 | -15.65 | - | - | - | - |
Common Dividends Paid | -5.87 | -7.58 | -8.04 | -6.84 | -1.2 | -3.23 |
Other Financing Activities | 16.09 | 0.18 | -27.93 | -0.53 | -35.94 | 0.69 |
Financing Cash Flow | -5.65 | -86.98 | 86.93 | 51.41 | 302.4 | 22.86 |
Foreign Exchange Rate Adjustments | 0.44 | 0.46 | 0.45 | 2.88 | -0.84 | -1.71 |
Net Cash Flow | 13.81 | -126.6 | 90.23 | -79.59 | 238.14 | 89.03 |
Free Cash Flow | 31.66 | -2.57 | -26.24 | -89.59 | -23.89 | 65.64 |
Free Cash Flow Margin | 4.11% | -0.35% | -4.72% | -21.15% | -7.37% | 25.20% |
Free Cash Flow Per Share | 0.08 | -0.01 | -0.07 | -0.24 | -0.07 | 0.21 |
Cash Income Tax Paid | 40.98 | 38.96 | 21.67 | 10.19 | 11.85 | 12.54 |
Levered Free Cash Flow | 23.45 | 3.33 | -47.08 | -106.39 | -62.77 | 60.64 |
Unlevered Free Cash Flow | 24.62 | 5.32 | -46.12 | -105.95 | -61.9 | 61.57 |
Change in Working Capital | -59.1 | -59.1 | -36.1 | -42.36 | -42.18 | 45.08 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.